ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 479,40
-0,68%
Dow Jones
39 118,86
-0,12%
DAX
18 235,45
0,17%
Brent Oil
84,85
0,00%
Bitcoin
60 710,98
0,66%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. JanOne Inc (JAN)

  7. JanOne Inc (JAN) Actualités

JAN

JanOne (JAN)

JanOne Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:JAN
DateHeureSourceTitreSymboleSociété
26/06/202413h30PR Newswire (US)JanOne Appoints Vay Tham as its Chief Revenue Officer and President of its Fintech Subsidiary, ALT5 SigmaNASDAQ:JANJanOne Inc
25/06/202413h30PR Newswire (US)ALT5 SIGMA, A JANONE COMPANY, ADDS PREPAID VISA®️ CARD INTEGRATION TO ALT5 SETTLEMENT PLATFORMNASDAQ:JANJanOne Inc
13/06/202413h30PR Newswire (US)JanOne's Subsidiary, Alt5, Reports 91% year over year increase in Transaction Volume to US $289 million for April and May 2024NASDAQ:JANJanOne Inc
11/06/202414h30PR Newswire (US)ALT5 Sigma, a wholly-owned subsidiary of JanOne, Launches ALT5 Settlement Platform aimed at the untapped $27.3 Billion Global Digital Content Creation MarketNASDAQ:JANJanOne Inc
05/06/202421h50Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:JANJanOne Inc
04/06/202423h12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:JANJanOne Inc
03/06/202418h05PR Newswire (US)JanOne Inc. added to the Russell Microcap® IndexNASDAQ:JANJanOne Inc
23/05/202423h02Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:JANJanOne Inc
16/05/202422h00PR Newswire (US)JanOne Closes Acquisition of ALT 5 Sigma Inc., a Leading Next Generation Blockchain FintechNASDAQ:JANJanOne Inc
13/05/202413h30PR Newswire (US)JanOne to Acquire ALT 5 Sigma Inc., a Leading Next Generation Blockchain Financial Technology ProviderNASDAQ:JANJanOne Inc
15/03/202414h00PR Newswire (US)JanOne Regains Compliance with Nasdaq's Listing RequirementsNASDAQ:JANJanOne Inc
21/09/202317h30PR Newswire (US)JanOne to Present at the Dawson James 8th Annual Investment ConferenceNASDAQ:JANJanOne Inc
21/09/202315h35GlobeNewswire Inc.Dawson James Securities Announces October Date for 8th Annual Small Cap Growth ConferenceNASDAQ:JANJanOne Inc
31/08/202319h30PR Newswire (US)JanOne to Present In Person and by Video at H.C. Wainwright's 25th Annual Global Investment ConferenceNASDAQ:JANJanOne Inc
29/08/202319h30PR Newswire (US)JanOne Earns US Patent for the Use of its Novel Formulation of Low-Dose Naltrexone, Jan123, to Treat Chronic PainNASDAQ:JANJanOne Inc
28/08/202323h20Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:JANJanOne Inc
25/08/202320h30PR Newswire (US)JanOne Wins "Best Abstract" Award at the Ohio Society of Interventional Pain Physicians Annual MeetingNASDAQ:JANJanOne Inc
24/08/202322h30Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:JANJanOne Inc
22/08/202323h30PR Newswire (US)JanOne Technologies Announces Closing of Registered Direct Offering Priced At-The-Market under Nasdaq RulesNASDAQ:JANJanOne Inc
19/08/202301h00PR Newswire (US)JanOne Technologies Announces Registered Direct Offering Priced At-The-Market under Nasdaq RulesNASDAQ:JANJanOne Inc
18/08/202318h42PR Newswire (US)JanOne to Present Prior Phase II Data on Diabetic Neuropathy at the Ohio Society of Interventional Pain Physicians Annual MeetingNASDAQ:JANJanOne Inc
16/08/202321h55Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:JANJanOne Inc
15/08/202322h39Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:JANJanOne Inc
28/06/202314h30PR Newswire (US)JanOne files international patent application for methods of using low dose naltrexone to treat chronic painNASDAQ:JANJanOne Inc
22/05/202322h32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:JANJanOne Inc
11/05/202322h31Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:JANJanOne Inc
21/04/202322h32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:JANJanOne Inc
18/04/202314h30PR Newswire (US)JanOne Completes Pre-IND Meeting with FDA on Jan123NASDAQ:JANJanOne Inc
17/04/202322h58Edgar (US Regulatory)Annual Report (10-k)NASDAQ:JANJanOne Inc
13/04/202314h30PR Newswire (US)JanOne to Present Data On Its Two Non-Opioid Drug Candidates at The Appalachian Region Spine and Pain Meeting on Drug Development Programs to Treat Pain on April 15, 2023NASDAQ:JANJanOne Inc
 Showing the most relevant articles for your search:NASDAQ:JAN

Dernières Valeurs Consultées

COIN
IOWNGBP
iOWN Token
TG
A3K039
Logicor Financing
USOTC
FUWAY
Furukawa Electric (PK)
COIN
XEDEUR
Exeedme
ASX
TPMKOD
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés